key: cord-0692902-zp1cscm9
authors: Lovey, Thibault; Bielecki, Michel; Gültekin, Nejla; Stettbacher, Andreas; Muggli, Franco; Stanga, Zeno; Farnham, Andrea; Deuel, Jeremy; Schlagenhauf, Patricia
title: Illness tracking in SARS-CoV-2 tested persons using a smartphone app: a non-interventional, prospective, cohort study
date: 2022-03-10
journal: New Microbes New Infect
DOI: 10.1016/j.nmni.2022.100967
sha: ce865bc65d138fd6938ced242b96487707dd67a5
doc_id: 692902
cord_uid: zp1cscm9

There are few data on the range and severity of symptoms of SARS-CoV-2 infection or the impact on life quality in infected, previously healthy, young adults such as Swiss Armed Forces personnel. It is also unclear if an app can be used to remotely monitor symptoms in persons who test positive. Using a smartphone app called ITITP (Illness Tracking in Tested Persons) and weekly pop-up questionnaires, we aimed to evaluate the spectrum, duration, and impact of symptoms reported after a positive SARS-CoV-2 test according to sex, age, location, and comorbidities, and to compare these to responses from persons who tested negative. We followed up 502 participants (57% active participation), including 68 (13.5%) positive tested persons. Hospitalisation was reported by 6% of the positive tested participants. We found that positives reported significantly more symptoms that are typical of COVID-19 compared to negatives. These symptoms with Odds Ratio (OR>1) were having difficulty breathing (OR 3.35; 95% CI: 1.16,9.65; p=0.03), having a reduced sense of taste (OR 5.45; 95% CI: 1.22, 24.34; p=0.03) and a reduced sense of smell (OR 18.24; 95% CI: 4.23, 78.69; p<0.001). Using a random forest model, we showed that tiredness was the single symptom that was rated as having a significant impact on daily activities, whereas the other symptoms, although frequent, had less impact. The study showed that the use of an app was feasible to remotely monitor symptoms in persons infected with SARS-CoV-2 and could be adapted for other settings and new pandemic phases such as the current Omicron wave.

The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2 continues and the epidemiological 27 situation is increasingly complex with new waves of infection and the emergence of highly transmissible 28 virus variants (1). Vaccines (2), wearing masks (3), social distancing (4), hand hygiene and community 29 mitigation measures (5) are recommended to reduce the impact of the pandemic. There are few data on 30 the range and severity of symptoms or the impact of the infection on life quality in young adults. Data 31 on the persistence of protective immunity after recovery from SARS-CoV-2 infection are scarce (6, 7). 32

Will young people who were infected with an ancestral variant of SARS-CoV-2 produce antibodies that 33 can cross neutralize the emerging and highly transmissible variants such as Omicron, or will they 34 become reinfected with newer variants? Several studies have reported data on patients with severe 35 disease (8) but few papers are evaluating young persons who test positive and who have mild illness or 36 who are asymptomatic. Such data are most important for young population groups as they constitute the 37 workforce of many economies and most likely to engage in social activities and larger events (9). The 38

Swiss Armed Forces have several bases throughout Switzerland where young recruits and military 39 personnel spend weeks to months as part of their training and military service. During the early period 40 of the pandemic, RT-PCR testing for SARS-CoV-2 was mandatory. We aimed to follow up on those 41 army recruits and personnel with a confirmed positive test for SARS-CoV-2 and compare them to those 42 who tested negative. Our goals were to evaluate the spectrum, duration, severity, and impact of 43 symptoms reported after a positive SARS-CoV-2 test according to sex, age and location and compare 44 these to responses from those who tested negative. Furthermore, we aimed to evaluate the feasibility of 45 using an app to identify clusters of symptoms and emerging symptoms such as ageusia (loss of taste 46 functions), anosmia (loss of smell functions) that could be predictive of SARS-CoV-2 infection. We 47 wanted to evaluate symptom duration and impact on daily life activities. A secondary objective was to 48 analyse the geolocation changes of positive cases. To follow up on the spectrum of symptoms, their evolution and resolution we designed a study using a 52 repurposed app for a weekly survey of tested persons (positives, and negatives as a control group) in the 53 army setting. The study app was called ITITP (Illness Tracking in Tested Persons). The University of 54 Zürich Travel Clinic, Epidemiology, Biostatistics, and Prevention Institute (EBPI), and the ETH 55

Wearable Computing Lab partnered in 2014 to develop and field test a smartphone app called "Tourist" 56 for use in travel medicine. Further expertise in using mobile apps to track infection has been gained in 57 a recent project called ITIT (Infection Tracking in Travelers) which received funding in March 2020 58 from the Swiss National Foundation (10). We used the knowledge and experience gained in these 59 projects to follow up on army recruits and personnel who tested positive or negative for SARS-CoV-2 60 before enrollment either with RT-PCR nasopharyngeal tests or serological tests. After approval by the 61 ethical commission of the Republic and Canton of Ticino, Comitato Etico Cantonale (BASEC 62

Number.2020-01146 CE 3637), we recruited participants at Swiss Armed Forces bases in Airolo and 63

Monte Ceneri, Canton Ticino, Switzerland. Inclusion criteria were completion of consent form, being 64 willing and able to participate and to complete the weekly electronic pop-up questionnaires (push 65 notification on smart phone). Tested persons (regardless of whether positive or negative) could 66 participate. After signing an informed consent form, they downloaded the smartphone app using a 67 provided QR code and completed a simple baseline questionnaire simple baseline questions (age, sex, 68 body height, body weight, date of positive test, hospitalised y/n, co-morbidities (such as asthma, high 69 blood pressure), and smoking habits. The pop-up weekly questionnaires were available in English, 70

German, French, and Italian and queried illness symptoms (Appendix 1, BOX 1) . All illness symptoms 71 reported were self-rated by the participants using a Likert scale ranging from 1 (none) to 5 (severe). 72

Anyone reporting illness symptoms was asked two additional questions on the impact of illness on their 73 activities and on their general mood (Appendix 1, BOX2) . The surveys were anonymous, and the 74 participants could elect to delete their data using a feature on the app. 75

In addition to the active data received via the weekly survey questionnaires, the app collected passive 76 data only if this was agreed by the participant. Allowing access to passive data was included in the they were filled out and uploaded to the server along with the user ID of the mobile device, which 79 enabled the mapping of locations where the participant completed the survey. The survey upload 80 locations were mapped over time and by whether or not the participant had tested positive or negative. 81

Data were analysed using R statistical Software Version 4.0.4, R Foundation for statistical computing, 82

Vienna, Austria (11). Symptom data were evaluated in a random forest model to predict impact on daily 83 activities, and we used the Gini Index to display the impact of the reported symptoms. Table 1) . Tests for homogeneity between the 97 sociodemographic characteristics and health determinants of our two groups of interest (those who tested 98 positive and those who tested negative) showed no significant differences ( Table 1) . 99 100

Of the 502 initial participants, 288 (57%) actively participated in the study by completing at least one 102 questionnaire. A total of 2,393 questionnaires were completed, representing an average of five (SD 11) 103 eight, SD sixteen; males four, SD ten) ( Table 2) . 105

Of the 288 participants who completed at least one weekly questionnaire, 49% (140/288) participated 106 for less than one month, 23% (65/288) between one and three months, 14% (39/288) from three to six 107 months, and 14% (39/288) longer than six months ( Table 2) . 108

The time between positive PCR or antigen test and response to the first questionnaire (start of follow-109 up) ranged from zero days to approximately one year with a median of 54 days. 110

We counted a total of 793 missing questionnaires over the entire observation period, which corresponds 111 to 24% (793/3184) of the missing weekly surveys in our dataset. With a median of eleven weeks for the 112 distribution of total missing weeks, most questionnaires were missed before the third month of follow-113 up. This corresponds to an average of three (SD five) missing weeks per participant with a maximum of 114 35 missing questionnaires and a minimum of zero. We can therefore report a survey response rate that 115 varies individually from 17% to 100% and an average of 83% (22) ( Table 2) . 116

Having a runny nose was the most common symptom, reported by 50% (145/288) of the participants 118 who completed questionnaires during period of the study, followed by headache 46% (131/288), and 119 tiredness 39% (111/288). Other reported symptoms were a decreased sense of taste 10% (29/288) and 120 a decreased sense of smell 11.8% (34/288) ( Table 3) . 121

Considering the highest score on the Likert scale from not at all to severe, we found a significant 122 difference between the two groups for decreased sense of smell (p=0.006) and decreased sense of taste 123 (p=0.031). Headache (p=0.078) and shortness of breath (p=0.053) tested just above the significance 124 threshold of alpha 0.05. ( frequently, but not significantly, in healthy participants (Figure 1) . 132

133 Using a random forest method, the four different levels of impact (none, mild, moderate and severe) 134 were classified based on the different symptoms that participants experienced during the week. We 135 found that the highest value for the average Gini Index reduction, and thus the most important variable 136 for our model, is tiredness (57.19), followed by runny nose (34.52). In contrast, some symptoms such 137 as decreased sense of smell and taste (10.34, 7.04) or fever (7.31) do not seem to affect daily activities 138 (Figure 2) . Symptoms persisted for periods ranging from of mean of 1.38 (SD 1.19) weeks for diarrhoea 139 to longer duration symptoms such as persistent loss of smell (mean 6 .45, SD 11.44) (Figure 3) . During the study, no reinfections were reported, but one patient reported a first infection after three 145 months of study participation between the second and third waves (12/02/2021). He presented all classic 146 symptoms with high fever (>39°C), significant impact on his daily activities, described his day as very 147 poor, but did not report hospitalization. 148

Geolocation data did not yield major differences between positives and negatives. Positives in general 149 did not seem to move far with the exception of the one positive that went to Northern Italy (Figure 4) . Our study showed that use of an app was feasible to remotely monitor symptoms in persons infected 153 with SARS-CoV-2. It was possible to show the range, duration and severity of symptoms experienced, 154 and the impact on daily activities. We showed that those who tested positive for SARS-CoV-2 reported 155 significantly more symptoms that are typical of COVID-19 compared to those who tested negative. 156

These were having difficulty breathing, having a reduced sense of taste (ageusia) and a reduced sense younger populations with COVID-19 (12). With regard to impact on daily activities, tiredness was the 159 single symptom that was rated as a major problem. In contrast, the other symptoms above, although 160 frequent, were not considered to have such a major impact. The finding is corroborated by other papers 161 that describe tiredness, fatigue, and exhaustion in SARS-CoV-2 infected persons (12). In contrast, a 162 metanalysis describing symptoms of a total of 24,410 adults (mean age 49 years) showed that the 163 cardinal symptoms of COVID-19 are fever and a new persistent cough (13). In our study, 6% (4/68) of 164 those who tested positive were hospitalized (mean: 22 (SD 0) years, male: 3, female: 1). Another study 165 of young adults aged 18-24 living in the United States recorded a 2.7% hospitalization rate with 0.8% 166 admitted to the ICU (14). This study shows that symptoms persisted for periods of mean of 1.38 (SD 167 1.19) weeks for diarrhoea to longer duration symptoms such as persistent loss of smell mean (6.45 168 weeks, SD 11.44). This is corroborated by a telephone survey of symptomatic adults (under 35 years 169 old) with mild COVID-19 where 35% did not return to their usual state of health two to three weeks 170 after testing (15). 171

Several apps focusing on different aspects such as health monitoring, contact tracing, pulse oximeter, 172 thermometer, prevalence, and research apps, emerged during the pandemic (16). The app, with the 173 largest amount of data and patients recruited, used for symptom tracking is probably the Zoe COVID 174 study app (17, 18) which evaluated age-and sex-based discrepancies in early symptoms and also found 175 different sets of relevant features between health-care workers and non-health-care workers. Another 176 app with a similar aim is the CoroNotes app by the University of Tübingen (19) which focuses on the 177 well-being of the users: "Users answer questions on whether they feel well, or whether they are 178 experiencing symptoms like headaches, aching limbs, or a fever, for instance". Another app, COVID 179 Control App was developed by John Hopkins University for patients to submit their daily body 180 temperature (20). To the best of our knowledge, ours is the only COVID app study that focuses on a 181 homogenous group of young, previously healthy persons and that combines geolocation with self-182 reported symptoms over a period of one year. The knowledge gained here could be applied in the future 183 in similar settings to allow for remote monitoring of positive cases in outbreak situations such as in 184 schools, hospitals, companies or in sport clubs or music groups. The remote surveillance, as pioneered here with the ITITP app, could be further developed so that positive cases could be monitored from their 186 homes but when pre-defined clusters or severe symptoms are reported, an alert could be created that 187 promotes medical intervention. 188

A strength of our study was the strong and collaborative response to the call for participants at the Swiss 190 Armed Forces bases in the Canton Ticino. Furthermore, our study population was homogenous, young 191 and familiar with smartphone and app technology, and found the app easy to download and use. 

The biological 212 and clinical significance of emerging SARS-CoV-2 variants

Comparing the clinical efficacy of 214 COVID-19 vaccines: a systematic review and network meta-analysis

An evidence 216 review of face masks against COVID-19

Social Distancing 218 Alters the Clinical Course of COVID-19 in Young Adults: A Comparative Cohort Study. Clin Infect 219 Dis

Covid-19 and community 221 mitigation strategies in a pandemic

Pilot 223 study of a well-being app to support New Zealand young people during the COVID-19 pandemic

SARS-CoV-226 2 re-infection risk in Austria

Clinical course and risk factors for mortality of 228 adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet

Concerts and COVID: can the beat go on? The Lancet

Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated 233 Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria -Full Text View -234

Team RC. R: A Language and Environment for Statistical Computing

COVID-19 sequelae in adults 237 aged less than 50 years: A systematic review

The 239 prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-240 19): A systematic review and meta-analysis of 148 studies from 9 countries

Among Persons Aged 0-24 Years -United States

Symptom 246 Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in 247 a Multistate Health Care Systems Network -United States

Early detection 252 of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological 253 surveillance study

Real-time tracking 255 of self-reported symptoms to predict potential COVID-19

Due to technical problems unfortunately the CoroNotes app is currently not 257 available

Appendix Box 1. List of questions on the weekly pop-up questionnaire, each rated on a Likert severity scale of 1-4 (1: mild, 2: moderate, 3: moderate-severe, 4: severe) Q1 . Symptoms Did you have a cough Did you have fever * Did you have a runny nose Did you have a sore throat Did you have headaches Did you have difficulty breathing Were you easily out of breath Did you have changes in your sense of smell Did you have changes in your sense of taste Did you feel more tired than usual Did you have concentration and/or memory problems Did you have diarrhoea Did you notice any skin reactions such as rash and/or itching Did you have night-time sweating Did you have other symptoms (please list) *If "yes" then a drop-down menu will ask for more information about the fever. The answer choices are: "not measured" "over 37.5°", "over 39°"